MeSH term
Frequency | Condition_Probility | Animals | 43 | 0.0 |
Disease Models, Animal | 9 | 0.0 |
Female | 27 | 0.0 |
Fluorescence | 2 | 0.0 |
Fundus Oculi | 2 | 2.0 |
Male | 27 | 0.0 |
*Membrane Glycoproteins | 38 | 4.0 |
Mice | 19 | 0.0 |
Mice, Knockout | 6 | 0.0 |
*Molecular Chaperones | 39 | 27.0 |
Mutation/*genetics | 2 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/*genetics/metabolism/pathology | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 93 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 60 | 0.0 |
Humans | 114 | 0.0 |
Molecular Biology | 3 | 1.0 |
Neuronal Ceroid-Lipofuscinosis/diagnosis/*genetics | 4 | 66.0 |
Pregnancy | 5 | 0.0 |
Gene Expression | 5 | 0.0 |
In Vitro | 3 | 0.0 |
Membrane Proteins/genetics | 5 | 1.0 |
Peptide Hydrolases/*genetics | 2 | 18.0 |
Proteins/genetics | 6 | 0.0 |
Transfection | 9 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Age Factors | 3 | 0.0 |
Antigens, CD/metabolism | 4 | 0.0 |
Antigens, Differentiation, Myelomonocytic/metabolism | 2 | 1.0 |
Brain/pathology | 3 | 0.0 |
Calcium-Binding Protein, Vitamin D-Dependent/metabolism | 2 | 8.0 |
Cell Count/methods | 2 | 3.0 |
Comparative Study | 10 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 2 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Molecular Chaperones/genetics | 6 | 27.0 |
Parvalbumins/metabolism | 2 | 18.0 |
Staining and Labeling/methods | 2 | 1.0 |
Protein Biosynthesis | 3 | 0.0 |
Adolescent | 20 | 0.0 |
Adult | 14 | 0.0 |
Child | 37 | 0.0 |
Child, Preschool | 24 | 0.0 |
Amino Acid Motifs | 4 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Molecular Sequence Data | 27 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/genetics | 4 | 50.0 |
Saccharomyces cerevisiae/genetics | 6 | 1.0 |
Age of Onset | 6 | 0.0 |
Genotype | 10 | 0.0 |
Phenotype | 12 | 0.0 |
Genetic Markers | 14 | 0.0 |
Genetic Screening | 4 | 0.0 |
Infant | 20 | 0.0 |
Membrane Proteins/*genetics | 4 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Lysosomes/enzymology | 3 | 4.0 |
Mitochondria/enzymology | 2 | 1.0 |
Neuronal Ceroid-Lipofuscinosis/*genetics/*metabolism | 2 | 100.0 |
Infant, Newborn | 4 | 0.0 |
Chromosomes, Human, Pair 16 | 6 | 4.0 |
Cloning, Molecular | 8 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Exons | 2 | 0.0 |
Gene Deletion | 4 | 0.0 |
Mutation | 15 | 0.0 |
Proteins/*genetics | 10 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Alleles | 10 | 0.0 |
G1 Phase | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 21 | 1.0 |
Aged | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/*diagnosis/genetics | 2 | 50.0 |
Chromosome Mapping | 21 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/*genetics | 35 | 58.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Pedigree | 14 | 0.0 |
Peptide Hydrolases/genetics | 3 | 33.0 |
*Point Mutation | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Cell Cycle | 2 | 0.0 |
*Cyclins | 14 | 73.0 |
Lipofuscin/metabolism | 2 | 22.0 |
Membrane Glycoproteins/genetics | 5 | 2.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Green Fluorescent Proteins | 6 | 0.0 |
Hydrogen-Ion Concentration | 6 | 0.0 |
Lysosomes/*metabolism | 3 | 3.0 |
Proteins/*physiology | 2 | 1.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/*metabolism | 6 | 46.0 |
Sequence Alignment | 4 | 0.0 |
Dog Diseases/*genetics | 3 | 13.0 |
Dogs | 4 | 0.0 |
Base Sequence | 18 | 0.0 |
Cell Line | 11 | 0.0 |
DNA | 3 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Membrane Glycoproteins/*metabolism | 6 | 1.0 |
Molecular Chaperones/*metabolism | 6 | 11.0 |
Restriction Mapping | 4 | 0.0 |
Rats | 3 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Linkage (Genetics) | 10 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/diagnosis/epidemiology/*genetics | 2 | 66.0 |
*Genes, Recessive | 2 | 1.0 |
Haplotypes | 4 | 0.0 |
Microscopy, Electron | 5 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/classification/*genetics | 3 | 75.0 |
Liver/chemistry | 2 | 2.0 |
Molecular Weight | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Sequence Deletion | 4 | 0.0 |
Cell Membrane/metabolism | 4 | 0.0 |
Cyclins/*metabolism | 2 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/etiology | 2 | 100.0 |
Time Factors | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Fungal Proteins/genetics | 2 | 1.0 |
Genetic Complementation Test | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
*Disease Models, Animal | 2 | 0.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Gene Library | 2 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Etoposide/pharmacology | 2 | 1.0 |
Immunoblotting | 3 | 0.0 |
CHO Cells | 3 | 0.0 |
Hamsters | 4 | 0.0 |
Luminescent Proteins/metabolism | 3 | 0.0 |
Phosphorylation | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Recombinant Fusion Proteins | 3 | 0.0 |
Endoplasmic Reticulum/metabolism | 2 | 0.0 |
Golgi Apparatus/metabolism | 4 | 2.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Cell-Free System | 3 | 1.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Lysosomes/metabolism | 4 | 2.0 |
Inbreeding | 2 | 8.0 |
Neuronal Ceroid-Lipofuscinosis/genetics/*veterinary | 2 | 100.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Biopsy | 2 | 0.0 |
Electroretinography | 2 | 1.0 |
English Abstract | 2 | 0.0 |
Exons/*genetics | 2 | 0.0 |
Rabbits | 3 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
Homozygote | 3 | 0.0 |
Biological Transport | 3 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/genetics/*metabolism | 2 | 100.0 |
Finland | 3 | 1.0 |
Electroencephalography | 2 | 0.0 |
Skin/pathology | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Lod Score | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Cyclins/*genetics | 3 | 2.0 |
*Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 1 | 4 | 1.0 |
Chromosomes, Human, Pair 13 | 2 | 1.0 |
Genetic Markers/genetics | 3 | 0.0 |
Neuronal Ceroid-Lipofuscinosis/diagnosis/*genetics/pathology | 4 | 100.0 |
*Variation (Genetics) | 2 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Molecular Chaperones/*genetics | 2 | 9.0 |
Fatty Acids/metabolism | 2 | 1.0 |
*Heterozygote Detection | 2 | 1.0 |
Cosmids | 4 | 1.0 |
Chromosomes, Artificial, Yeast | 3 | 0.0 |
*Chromosomes, Human, Pair 16 | 14 | 5.0 |
DNA Primers | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
*Linkage Disequilibrium | 2 | 1.0 |
Arylsulfotransferase/*genetics | 2 | 28.0 |
Hybrid Cells | 2 | 0.0 |
Cyclins/*physiology | 2 | 3.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
DNA, Satellite/genetics | 2 | 1.0 |
Genes, Recessive | 2 | 0.0 |
Biotinylation | 2 | 1.0 |
Proteins/*metabolism | 2 | 0.0 |
Brain Chemistry | 2 | 0.0 |
Membrane Proteins/*chemistry/genetics/metabolism | 2 | 16.0 |
Proteins/*chemistry/genetics/metabolism | 2 | 20.0 |
Glycosylation | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
